Congress Needs To Review “Authorized” Generics, Hatch And Waxman Agree

Congress will likely have to look at the issue of "authorized" generics, Sen. Orrin Hatch (R-Utah) and Rep. Henry Waxman (D-Calif.) said during an Oct. 6 Drug & Device Dialogue audio conference sponsored by FDC Reports and Polidais LLC

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Archive

More from Pink Sheet